Incorporating PARP inhibitors in translational studies for Ewing’s sarcoma
Goshorn, David Ross, Stewart, Elizabeth, Shelat, Anang, Dyer, Michael A., Bradley, Cori, Pappo, Alberto S.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Phase I study of talazoparib and irinotecan in children and young adults with recurrent/refractory solid tumors
Federico, Sara Michele, Stewart, Elizabeth, Coleman, Jamie L., Bishop, Michael William, Santana, Victor M., Lam, Catherine, Hawkins, Dana, Wu, Jianrong, Mao, Shenghua, Goshorn, David Ross, Pappo, Alberto S., Dyer, Michael A.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Preclinical evaluation of PARP inhibitors in combination with DNA-damaging agents in a Ewing sarcoma orthotopic xenograft model
Stewart, Elizabeth, Goshorn, David Ross, Dyer, Michael A., Shelat, Anang, Bradley, Cori, Pappo, Alberto S., Loh, Amos
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article